Zealand Pharma A/S Statistics Share Statistics Zealand Pharma A/S has 0
shares outstanding. The number of shares has increased by -0.6%
in one year.
Shares Outstanding n/a Shares Change (YoY) -0.6% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 36.79M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 75.47K, so 0% of the outstanding
shares have been sold short.
Short Interest 75.47K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 86.16
Valuation Ratios The PE ratio is -5.26 and the forward
PE ratio is null.
Zealand Pharma A/S's PEG ratio is
-0.26.
PE Ratio -5.26 Forward PE n/a PS Ratio 18.3 Forward PS n/a PB Ratio 5.77 P/FCF Ratio -4.34 PEG Ratio -0.26
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Zealand Pharma A/S.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.15,
with a Debt / Equity ratio of 0.85.
Current Ratio 5.15 Quick Ratio 4.8 Debt / Equity 0.85 Debt / EBITDA -0.8 Debt / FCF -0.64 Interest Coverage -250.02
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.23M Profits Per Employee $-4.3M Employee Count 237 Asset Turnover 0.14 Inventory Turnover 1
Taxes Income Tax -8.79M Effective Tax Rate 0.86%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.34, so Zealand Pharma A/S's
price volatility has been higher than the market average.
Beta 1.34 52-Week Price Change n/a 50-Day Moving Average 17.62 200-Day Moving Average n/a Relative Strength Index (RSI) 49.2 Average Volume (20 Days) 1,758
Income Statement In the last 12 months, Zealand Pharma A/S had revenue of 292.57M
and earned -1.02B
in profits. Earnings per share was -26.54.
Revenue 292.57M Gross Profit 173.75M Operating Income -1.02B Net Income -1.02B EBITDA -982.6M EBIT -1.02B Earnings Per Share (EPS) -26.54
Full Income Statement Balance Sheet The company has 1.13B in cash and 787.43M in
debt, giving a net cash position of 341.67M.
Cash & Cash Equivalents 1.13B Total Debt 787.43M Net Cash 341.67M Retained Earnings -3.31B Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1.21B
and capital expenditures -22.13M, giving a free cash flow of -1.23B.
Operating Cash Flow -1.21B Capital Expenditures -22.13M Free Cash Flow -1.23B FCF Per Share -32.16
Full Cash Flow Statement Margins Gross margin is 59.39%, with operating and profit margins of -349.61% and -348.01%.
Gross Margin 59.39% Operating Margin -349.61% Pretax Margin -351.01% Profit Margin -348.01% EBITDA Margin -335.85% EBIT Margin -349.61% FCF Margin -421.82%
